Kappac Pharma Ltd.
| BSE: 506938 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE601D01011 |
| BSE 05:30 | 01 Jan | Kappac Pharma Ltd |
| NSE 05:30 | 01 Jan | Kappac Pharma Ltd |
Kappac Pharma Ltd. (KAPPACPHARMA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 683.00 | 0.55 | 696.80 | 434.25 | 163872.18 |
| Divi's Lab. | 4056.00 | -0.16 | 4147.30 | 2094.60 | 107666.52 |
| Dr Reddy's Labs | 5199.90 | 0.66 | 5514.65 | 3613.45 | 86474.34 |
| Cipla | 890.90 | 0.80 | 966.00 | 565.90 | 71846.63 |
| Cadila Health. | 605.10 | 0.55 | 610.85 | 318.10 | 61944.09 |
| Aurobindo Pharma | 1017.35 | 0.88 | 1038.00 | 626.70 | 59606.54 |
| Lupin | 1217.00 | 1.67 | 1240.80 | 808.50 | 55221.38 |
| Apollo Hospitals | 3334.95 | -0.29 | 3396.00 | 1253.25 | 47949.91 |
| Biocon | 381.25 | 0.43 | 487.70 | 320.90 | 45772.87 |
| Torrent Pharma. | 2641.25 | 1.22 | 3040.00 | 2232.00 | 44695.23 |
| Gland Pharma | 2647.70 | 0.56 | 2879.00 | 1701.00 | 43395.80 |
| Piramal Enterp. | 1674.95 | -1.47 | 2008.20 | 839.05 | 37778.50 |
| Alkem Lab | 2932.00 | 2.46 | 3150.00 | 2223.55 | 35052.06 |
| Abbott India | 15372.10 | -0.34 | 18450.00 | 13970.10 | 32665.71 |
| Ipca Labs. | 2095.20 | -0.09 | 2455.55 | 1467.00 | 26577.61 |
| Laurus Labs | 488.95 | 1.55 | 504.15 | 84.40 | 26237.06 |
| Glaxosmi. Pharma | 1459.65 | -0.26 | 1805.00 | 1258.00 | 24727.93 |
| Pfizer | 5335.40 | 0.21 | 5875.00 | 3940.00 | 24409.46 |
| Dr Lal Pathlabs | 2871.90 | 1.16 | 3398.95 | 1500.00 | 23934.41 |
| Syngene Intl. | 577.00 | -1.71 | 644.65 | 310.40 | 23080.00 |
Quick Links for Kappac Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
